US Stock MarketDetailed Quotes

INSP Inspire Medical Systems

Watchlist
  • 194.000
  • +4.870+2.57%
Close Nov 27 16:00 ET
  • 194.000
  • 0.0000.00%
Post 16:39 ET
5.81BMarket Cap174.77P/E (TTM)

Inspire Medical Systems Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
32.54%203.19M
29.65%195.89M
28.24%164.01M
53.19%624.8M
39.60%192.51M
40.40%153.3M
65.33%151.09M
84.34%127.9M
74.75%407.86M
75.90%137.9M
Operating revenue
32.54%203.19M
29.65%195.89M
28.24%164.01M
53.19%624.8M
39.60%192.51M
40.40%153.3M
65.33%151.09M
84.34%127.9M
74.75%407.86M
75.90%137.9M
Cost of revenue
32.88%32.4M
23.05%29.84M
24.48%24.76M
46.07%96.58M
26.64%28.05M
23.23%24.38M
71.11%24.25M
98.80%19.89M
98.67%66.12M
98.57%22.15M
Gross profit
32.48%170.79M
30.91%166.04M
28.93%139.25M
54.57%528.22M
42.08%164.45M
44.20%128.92M
64.27%126.84M
81.90%108.01M
70.77%341.74M
72.14%115.75M
Operating expense
9.89%156.48M
12.20%160.94M
21.15%154.47M
46.02%568.49M
33.66%155.16M
33.58%142.39M
57.25%143.44M
69.03%127.51M
62.25%389.33M
68.08%116.08M
Selling and administrative expenses
15.14%130.39M
17.28%132.08M
23.17%125.62M
40.93%451.96M
30.86%124.11M
32.29%113.25M
46.86%112.62M
60.45%101.99M
58.27%320.69M
61.37%94.84M
Research and development costs
-10.50%26.08M
-6.37%28.86M
13.05%28.85M
69.77%116.54M
46.14%31.05M
38.83%29.14M
112.06%30.82M
114.99%25.52M
83.79%68.65M
106.41%21.25M
Operating profit
206.29%14.32M
130.72%5.1M
21.95%-15.22M
15.38%-40.27M
2,875.22%9.3M
21.65%-13.47M
-18.51%-16.6M
-21.44%-19.5M
-19.43%-47.59M
81.60%-335K
Net non-operating interest income expense
7.19%5.89M
19.50%5.88M
38.61%5.92M
509.55%20.56M
74.24%5.87M
691.79%5.5M
2,598.48%4.92M
966.73%4.27M
268.40%3.37M
744.17%3.37M
Non-operating interest income
7.19%5.89M
19.50%5.88M
38.61%5.92M
307.13%20.56M
74.24%5.87M
307.04%5.5M
1,557.24%4.92M
12,467.65%4.27M
3,940.00%5.05M
22,360.00%3.37M
Non-operating interest expense
----
----
----
--0
----
----
----
----
-21.19%1.68M
--0
Other net income (expense)
152.68%118K
-121.31%-135K
-452.94%-60K
-297.96%-195K
-69.71%73K
-121.78%-224K
57.64%-61K
137.78%17K
58.12%-49K
992.59%241K
Other non- operating income (expenses)
152.68%118K
-121.31%-135K
-452.94%-60K
-297.96%-195K
-69.71%73K
-121.78%-224K
57.64%-61K
137.78%17K
58.12%-49K
992.59%241K
Income before tax
347.88%20.33M
192.40%10.85M
38.49%-9.36M
55.03%-19.91M
365.34%15.24M
50.61%-8.2M
18.19%-11.74M
8.35%-15.21M
-5.48%-44.27M
238.13%3.28M
Income tax
437.94%1.83M
392.06%1.05M
200.93%650K
103.43%1.25M
281.60%477K
38.21%340K
50.70%214K
116.00%216K
751.39%613K
525.00%125K
Net income
316.59%18.5M
181.94%9.79M
35.13%-10.01M
52.87%-21.15M
368.67%14.76M
49.31%-8.54M
17.52%-11.95M
7.61%-15.42M
-6.75%-44.88M
231.74%3.15M
Net income continuous Operations
316.59%18.5M
181.94%9.79M
35.13%-10.01M
52.87%-21.15M
368.67%14.76M
49.31%-8.54M
17.52%-11.95M
7.61%-15.42M
-6.75%-44.88M
231.74%3.15M
Minority interest income
Net income attributable to the parent company
316.59%18.5M
181.94%9.79M
35.13%-10.01M
52.87%-21.15M
368.67%14.76M
49.31%-8.54M
17.52%-11.95M
7.61%-15.42M
-6.75%-44.88M
231.74%3.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
316.59%18.5M
181.94%9.79M
35.13%-10.01M
52.87%-21.15M
368.67%14.76M
49.31%-8.54M
17.52%-11.95M
7.61%-15.42M
-6.75%-44.88M
231.74%3.15M
Basic earnings per share
313.79%0.62
180.49%0.33
35.85%-0.34
55.00%-0.72
354.55%0.5
51.67%-0.29
22.64%-0.41
13.11%-0.53
-3.90%-1.6
222.22%0.11
Diluted earnings per share
306.90%0.6
178.05%0.32
35.85%-0.34
55.00%-0.72
390.00%0.49
51.67%-0.29
22.64%-0.41
13.11%-0.53
-3.90%-1.6
211.11%0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 32.54%203.19M29.65%195.89M28.24%164.01M53.19%624.8M39.60%192.51M40.40%153.3M65.33%151.09M84.34%127.9M74.75%407.86M75.90%137.9M
Operating revenue 32.54%203.19M29.65%195.89M28.24%164.01M53.19%624.8M39.60%192.51M40.40%153.3M65.33%151.09M84.34%127.9M74.75%407.86M75.90%137.9M
Cost of revenue 32.88%32.4M23.05%29.84M24.48%24.76M46.07%96.58M26.64%28.05M23.23%24.38M71.11%24.25M98.80%19.89M98.67%66.12M98.57%22.15M
Gross profit 32.48%170.79M30.91%166.04M28.93%139.25M54.57%528.22M42.08%164.45M44.20%128.92M64.27%126.84M81.90%108.01M70.77%341.74M72.14%115.75M
Operating expense 9.89%156.48M12.20%160.94M21.15%154.47M46.02%568.49M33.66%155.16M33.58%142.39M57.25%143.44M69.03%127.51M62.25%389.33M68.08%116.08M
Selling and administrative expenses 15.14%130.39M17.28%132.08M23.17%125.62M40.93%451.96M30.86%124.11M32.29%113.25M46.86%112.62M60.45%101.99M58.27%320.69M61.37%94.84M
Research and development costs -10.50%26.08M-6.37%28.86M13.05%28.85M69.77%116.54M46.14%31.05M38.83%29.14M112.06%30.82M114.99%25.52M83.79%68.65M106.41%21.25M
Operating profit 206.29%14.32M130.72%5.1M21.95%-15.22M15.38%-40.27M2,875.22%9.3M21.65%-13.47M-18.51%-16.6M-21.44%-19.5M-19.43%-47.59M81.60%-335K
Net non-operating interest income expense 7.19%5.89M19.50%5.88M38.61%5.92M509.55%20.56M74.24%5.87M691.79%5.5M2,598.48%4.92M966.73%4.27M268.40%3.37M744.17%3.37M
Non-operating interest income 7.19%5.89M19.50%5.88M38.61%5.92M307.13%20.56M74.24%5.87M307.04%5.5M1,557.24%4.92M12,467.65%4.27M3,940.00%5.05M22,360.00%3.37M
Non-operating interest expense --------------0-----------------21.19%1.68M--0
Other net income (expense) 152.68%118K-121.31%-135K-452.94%-60K-297.96%-195K-69.71%73K-121.78%-224K57.64%-61K137.78%17K58.12%-49K992.59%241K
Other non- operating income (expenses) 152.68%118K-121.31%-135K-452.94%-60K-297.96%-195K-69.71%73K-121.78%-224K57.64%-61K137.78%17K58.12%-49K992.59%241K
Income before tax 347.88%20.33M192.40%10.85M38.49%-9.36M55.03%-19.91M365.34%15.24M50.61%-8.2M18.19%-11.74M8.35%-15.21M-5.48%-44.27M238.13%3.28M
Income tax 437.94%1.83M392.06%1.05M200.93%650K103.43%1.25M281.60%477K38.21%340K50.70%214K116.00%216K751.39%613K525.00%125K
Net income 316.59%18.5M181.94%9.79M35.13%-10.01M52.87%-21.15M368.67%14.76M49.31%-8.54M17.52%-11.95M7.61%-15.42M-6.75%-44.88M231.74%3.15M
Net income continuous Operations 316.59%18.5M181.94%9.79M35.13%-10.01M52.87%-21.15M368.67%14.76M49.31%-8.54M17.52%-11.95M7.61%-15.42M-6.75%-44.88M231.74%3.15M
Minority interest income
Net income attributable to the parent company 316.59%18.5M181.94%9.79M35.13%-10.01M52.87%-21.15M368.67%14.76M49.31%-8.54M17.52%-11.95M7.61%-15.42M-6.75%-44.88M231.74%3.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 316.59%18.5M181.94%9.79M35.13%-10.01M52.87%-21.15M368.67%14.76M49.31%-8.54M17.52%-11.95M7.61%-15.42M-6.75%-44.88M231.74%3.15M
Basic earnings per share 313.79%0.62180.49%0.3335.85%-0.3455.00%-0.72354.55%0.551.67%-0.2922.64%-0.4113.11%-0.53-3.90%-1.6222.22%0.11
Diluted earnings per share 306.90%0.6178.05%0.3235.85%-0.3455.00%-0.72390.00%0.4951.67%-0.2922.64%-0.4113.11%-0.53-3.90%-1.6211.11%0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data